Celltrion shares keep fluctuating

Published: 2013-04-22 07:00:00

Updated: 2013-04-22 07:00:00

Celltrion shares have been still fluctuating after Chairman Seo Jung-jin’s surprise announcement about selling his controlling stake in a biosimilar drugs company to a multinational firm.

Its stock fell on Thursday to close at 36,850 won per share by investors’ massive selling for the recent t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK